Table 2.
FFAs | Control | HFD | ||||
---|---|---|---|---|---|---|
Pre-PHx | 24 h after PHx | 48 h after PHx | Pre-PHx | 24 h after PHx | 48 h after PHx | |
C12:0 | 0.056 | 0.080 | 0.056 | 0.063 | 0.148 | 0.100 |
C14:0 | 0.404 | 0.504 | 0.262 | 0.349 | 1.202 | 0.766 |
C16:0 | 9.842 | 17.652 | 10.684 | 15.465 | 33.478 | 29.782 |
C16:1 | 0.652 | 2.496 | 0.730 | 1.216 | 5.702 | 3.492 |
C18:0 | 6.964 | 7.972 | 7.816 | 7.976 | 10.566 | 10.394 |
C18:1 ω9 | 4.266 | 13.600 | 5.602 | 15.061 | 46.372 | 38.826 |
C18:2 ω6 | 7.164 | 22.450 | 10.430 | 7.398 | 22.942 | 18.284 |
C18:3 ω6 | 0.092 | 0.204 | 0.128 | 0.171 | 0.350 | 0.396 |
C18:3 ω3 | 0.192 | 0.946 | 0.230 | 0.252 | 1.440 | 0.922 |
C20:0 | 0.164 | 0.236 | 0.168 | 0.240 | 0.276 | 0.354 |
C20:1 ω9 | 0.146 | 0.418 | 0.246 | 0.368 | 0.890 | 0.858 |
C20:2 ω6 | 0.084 | 0.224 | 0.120 | 0.130 | 0.348 | 0.258 |
C20:3 ω9 | 0.022 | 0.020 | 0.000 | 0.085 | 0.132 | 0.116 |
C20:3 ω6 | 0.504 | 0.626 | 0.516 | 0.500 | 0.836 | 0.814 |
C20:4 ω6 | 3.182 | 3.300 | 2.972 | 5.225 | 6.200 | 5.252 |
C20:5 ω3 | 0.476 | 0.700 | 0.370 | 0.106 | 0.530 | 0.296 |
C22:0 | 0.188 | 0.198 | 0.156 | 0.236 | 0.204 | 0.218 |
C22:4 ω6 | 0.050 | 0.140 | 0.088 | 0.248 | 0.614 | 0.484 |
C22:5 ω3 | 0.268 | 0.686 | 0.356 | 0.286 | 0.832 | 0.750 |
C22:6 ω3 | 0.120 | 0.116 | 0.116 | 0.059 | 0.080 | 0.104 |
C24:0 | 3.912 | 6.900 | 5.268 | 3.814 | 5.406 | 6.776 |
C24:1 ω9 | 0.160 | 0.168 | 0.162 | 0.081 | 0.092 | 0.110 |
Values are expressed as mg FFA/g LW. In each group, hepatic lipid extracts from same time points were mixed together for measurement of FFA components. C16:0; palmitic acid, C18:1; oleic acid